arrow
D

Daniel Junker

Eberhard Karls University of Tubingen
H指数:14
被引数:1,440

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease

单价XBB.1.5适应新型冠状病毒肺炎mRNA疫苗在炎症性肠病患者中的全身和粘膜免疫原性

2024-07-154
OAAI
STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease
2023-08-126
PRE
Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations
2022-11-1824
OAAI
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients
2022-10-0613
OAAI
Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants
2022-07-157
OAAI
COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants
2022-05-0315
OAAI
Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination
2022-04-0113
OAAI
Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany
2022-02-167
OAAI
Robust and durable serological response following pediatric SARS-CoV-2 infection

小儿SARS-CoV-2感染后稳健持久的血清学反应

2022-01-1055
OAAI
Biparatopic nanobodies protect mice from lethal challenge with SARS-CoV-2 variants of concern

双互补位纳米抗体可保护小鼠免受SARS-CoV-2变异的致命攻击

2021-12-2019
OA
Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses
2021-12-0131
OAAI
Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
2021-05-2591
OAAI
NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodies

NeutrobodyPlex-使用纳米抗体监测SARS-CoV-2中和免疫反应

2021-04-2737
OA
Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic Coronaviridae and SARS-CoV-2
2021-03-165
OAAI
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
2021-02-1955
OAAI
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

SARS-CoV-2-derived肽定义异源和COVID-19-induced T细胞识别

2020-09-30426
OAAI